Arena Pharmaceuticals Inc (ARNA) Financials

$99.99

$0.00 (0.00%)

As on 14-Mar-2022 09:30EDT

Market cap

$6,165 Mln

Revenue (TTM)

$-3 Mln

P/E Ratio

--

P/B Ratio

9.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	0.05	0.32	806.43	17.97	21.34	123.98
Cost of Revenue	--	--	231.50	115.03	70.99	15.34
Gross Profit	0.05	0.32	806.43	17.97	21.34	108.63
Operating Expenses	554.35	426.94	323.67	162.73	101.29	97.63
Operating Profit (EBIT)	-624.30	-426.64	482.75	-144.78	-79.95	11.01
Other Income	12.03	26.43	29.93	11.64	2.23	0.76
Profit before Tax	-616.43	-404.73	507.89	-138.83	-95.81	-22.85
Provision for Tax	--	--	110.33	-110.27	-1.33	-0.38
Profit after Tax (Net Income)	-616.43	-404.73	397.56	-29.40	-91.41	-22.52
Minority Interest	--	--	--	--	-1.33	-0.38
Consolidated Profit	-616.43	-404.73	397.56	-29.40	-91.41	-22.52

Liabilities ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	673.24	1,080.47	1,071.47	606.26	207.14	39.90
Minority Interest	--	--	--	--	--	0.49
Non-Current Liabilities	45.15	52.17	57.69	50.73	59.80	64.74
Current Liabilities	66.32	58.08	44.97	29.92	72.33	63.88
Total Liabilities	784.71	1,190.72	1,174.12	686.90	339.28	169.01

Assets ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	215.24	51.41	414.19	226.18	58.00	49.12
Current Assets	569.47	1,139.31	759.93	460.73	281.28	119.89
Total Assets	784.71	1,190.72	1,174.12	686.90	339.28	169.01
Total Debt*	41.21	45.61	49.43	52.71	61.75	65.27
Net Current Assets	503.15	1,081.23	714.97	430.81	208.95	--

Cashflow ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	-452.02	-353.09	568.69	-132.21	-66.64	-62.14
Cash Flow from Investing Activities	321.40	-21.40	-496.95	-251.27	-112.39	-0.75
Cash from Financing Activities	135.41	350.61	9.87	385.03	245.29	-2.29
Net Cash Inflow / Outflow	4.79	-23.89	81.61	2.20	68.13	-65.47

Financials Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS ($)	-10.11	-7.36	7.65	-0.63	-2.77	-0.94
Cash EPS ($)	-10.04	-7.29	7.71	-0.55	-2.64	-0.94
Adjusted Book Value ($)	11.04	19.64	20.61	12.90	6.28	1.66
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-7.41	-6.42	10.94	-2.81	-2.02	-2.59
Free Cash Flow per Share ($)	-8.57	-6.43	10.84	-2.83	-2.02	-2.63

Profitability Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	-66.98	-36.02	44.67	-6.34	-48.87	-19.84
ROE (%)	-70.30	-37.62	47.39	-7.23	-74.00	-48.19
ROA (%)	-62.41	-34.23	42.72	-5.73	-35.97	-10.58
EBIT Margin (%)	-1,133,840.74	-125,457.99	63.57	-745.51	-399.72	8.88
Net Margin (%)	-5,103.34	-1,513.19	47.53	-99.27	-387.83	-18.05
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	-0.83	-1.00	43.88	-0.16	-0.83	2.23
EBIT Growth (%)	-52.99	-178.06	482.68	-57.08	-874.71	111.09
Net Profit Growth (%)	-52.31	-201.81	1,452.27	67.84	-305.96	79.15
EPS Growth (%)	-0.37	-1.96	13.22	0.77	-1.95	0.79
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Price / Earnings	-9.20	-10.44	5.94	-62.27	-12.26	-1.51
Price / Book Value	8.42	3.91	2.20	3.02	5.41	0.85
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-8.48	-7.99	3.24	-11.04	-11.55	0.42
Close Price ($)	92.94	76.83	45.42	38.95	33.97	14.20
High Price ($)	94.08	90.19	64.48	50.05	35.09	21.60
Low Price ($)	45.50	32.95	38.18	30.00	11.30	13.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	0.06	0.04	0.05	0.09	0.30	1.64
Short term debt to equity ratio	0.01	0.00	0.00	0.01	0.02	0.09
Current Ratio	8.59	19.62	16.90	15.40	3.89	1.88
Quick Ratio	--	--	--	--	3.89	1.77
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	555.56	--	0.21	28.30	67.40	16.26
Asset Turnover	0.00	0.00	0.87	0.04	0.08	0.58
Receivable days	2,029.17	1,893.80	1.53	197.85	295.66	36.97
Inventory Days	--	--	--	--	17.26	192.97
Payable days	--	--	9.65	12.37	45.27	350.13
Cash Conversion Cycle	--	--	--	185.48	267.65	-120.19